Cholangiocarcinoma staging is dependent on whether the tumor is primarily intrahepatic (ICC), hilar/perihilar (Klatskin), or extrahepatic.
Tumor resection is currently the most optimal treatment and the ability of the tumor to infiltrate longitudinally and radially along the biliary tree necess...
As expected there are a number of different staging systems for hepatoblastoma.
PRETEXT grouping system of pediatric liver tumors
not specific to hepatoblastoma; used in all pediatric liver tumors
Intergroup staging system
specific for hepatoblastoma (see below)
Intergroup staging ...
Hepatocellular carcinoma staging classifications supersede the typical TNM staging system seen in most other epithelial cancers, as the TNM staging system has been found to not be as prognostically useful for stratification of patients with hepatocellular carcinoma. Several substitute staging sy...
The American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) introduced a unique staging system for the intrahepatic cholangiocarcinoma in their 7th edition in 2010. They further refined the staging system in the 8th edition.
T: primary tumor
Barcelona clinic liver cancer (BCLC) staging uses a set of criteria to guide the management of patients with hepatocellular carcinoma (HCC).
The classification takes the following variables into account 1,2:
performance status (PS)
radiologic tumor extent
The Okuda staging system was an advance on earlier hepatocellular (HCC) staging classifications, in that it incorporated both cancer-related variables and liver function related variables to determine prognosis 1:
disease involving >50% of hepatic parenchyma
albumin ≤3 mg/dL
The PRETEXT system proposed by the International Childhood Liver Tumors Strategy Group (previously called Société Internationale d’Oncologie Pédiatrique - Epithelial Liver Tumor Study Group - SIOPEL) aims for staging and risk stratification of liver tumors at diagnosis.
It is used to describe ...
Staging of pancreatic ductal adenocarcinoma is traditionally done according to American Joint Committee on Cancer (AJCC) / Union for International Cancer Control (IUCC) TNM system. In 2017 new edition (8th edition) AJCC published with some major changes; now exocrine and endocrine tumors of the...